Publications

Publications

Filter Results: (1,248) Arrow Down
Filter Results: (1,248) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 25 of 1,248 Results →
  • Forthcoming
  • Article

Achieving Epilepsy Care for All: Ecosystem-Based Transformation

By: Susanna Gallani, Bernice Martin Lee and Lidia M. V. R. Moura
Epilepsy exemplifies many of the systemic challenges of modern health care— fragmented care delivery, inequitable access, financial strain, and so on. The current “system of systems” (SoS) structure of U.S. health care fosters siloed operations among its member systems... View Details
Keywords: Healthcare Delivery; Epilepsy; Seizures; Health Care and Treatment; Health Disorders; Equality and Inequality; Framework; Service Delivery
Related
  • 07 Jan 2010
  • Working Paper Summaries

International Differences in the Size and Roles of Corporate Headquarters: An Empirical Examination

Keywords: by David Collis, David Young & Michael Goold
  • Research Summary

Putting Patients First: Marketing Strategies for Treating HIV in Developing Nations

It is more than mere coincidence that the highest rates of HIV occur in the world’s poorest countries. Of the over 40 million people currently living with HIV, 95 percent are in the developing world. The first half of this paper explores the economics of HIV and... View Details

    Stefan H. Thomke

    Stefan Thomke (sthomke@hbs.edu), an authority on the management of innovation, is the William Barclay Harding Professor of Business Administration at Harvard Business School. He has worked with firms on product, process, and... View Details

    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
    • 16 Aug 2011
    • Working Paper Summaries

    Managing Political Risk in Global Business: Beiersdorf 1914-1990

    Keywords: by Geoffrey Jones & Christina Lubinski; Beauty & Cosmetics
    • Web

    2023 Reunion Presentations - Alumni

    such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy enabled these changes in many ways: allowing access to telemedicine and pharmaceuticals by mail; redefining... View Details
    • October 1982 (Revised May 1992)
    • Case

    Johnson & Johnson: The Tylenol Tragedy

    By: Stephen A. Greyser
    In October 1982, Johnson & Johnson was confronted with a major crisis when seven deaths were attributed to poisoned Tylenol. The case reviews the facts as known a week after the incident occurred, and raises a wide range of questions regarding consumer behavior,... View Details
    Keywords: Consumer Behavior; Corporate Social Responsibility and Impact; Competitive Strategy; Crisis Management; Health Care and Treatment; Pharmaceutical Industry
    Related

      W. Carl Kester

      Carl Kester is a Baker Foundation Professor and the George Fisher Baker Jr. Professor of Business Administration, Emeritus at Harvard Business School. He is a member of the Finance Unit. He served as Deputy Dean for Academic Affairs (2006-2010), Chairman of the... View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

        Paul M. Healy

        Paul Healy is the James R. Williston Professor at the Harvard Business School. His research covers a broad range of topics, including white collar crime, governance, business ethics, financial analysis, and Wall Street research. He joined the HBS faculty in 1998,... View Details

        Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals
        • 13 Jul 2020
        • Research & Ideas

        Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

        As chairman and CEO of the leading vaccine producer in the world, pharmaceutical giant Merck & Co., Ken Frazier has one of the highest-profile positions in global business. But Frazier, who is leading one of the firms on a charge to... View Details
        Keywords: by Staff; Pharmaceutical
        • 09 Oct 2020
        • Blog Post

        4 Things To Know About the MS/MBA Biotech

        and pharmaceutical management. I learned about value-based approaches to drug pricing and concluded that overseeing a mission-driven pharmaceutical company would provide me with the platform and the... View Details
        • Web

        Sample Student Projects - Institute For Strategy And Competitiveness

        Cluster (2013) Belgium Pharmaceuticals (2011) Botswana The Botswana Textiles Cluster (2007) Brazil Brazilian Petrochemical Cluster (2017) Sao Paulo Plastics (2013) Leather Footwear in Brazil (2012) Brazil Aviation (2011) Bio-ethanol... View Details
        • Web

        Academics - Health Care

        care organization Redesigning urgent care triage for a major academic hospital Developing a China business model for a large pharmaceutical company Cross-Registration HBS students may take graduate-level courses at several other schools... View Details

          Michael A. Wheeler

          Mike Wheeler joined the HBS faculty in 1993 and has taught extensively in its MBA, Executive, and distance learning programs. His highly interactive 8-week/40-hour HBS Online Negotiation... View Details

          Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

            Dafna Bearson

            Dafna Bearson is a doctoral candidate in the Strategy Unit at Harvard Business School. Her research interests lie at the intersection of strategy and innovation. Specifically, her research focuses on intellectual property commercialization strategy in startups... View Details

            Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals
            • 14 Jul 2023
            • Blog Post

            Harvard Business School Announces Its 2023-2024 Blavatnik Fellows

            Harvard Medical School; the Wyss Institute at the Harvard University; and the Institute for Medical Engineering and Science (IMES) at MIT, where she engineered drug delivery systems in collaboration with pharmaceutical companies such as... View Details
            • 15 Jul 2013
            • Research & Ideas

            Five Imperatives for Improving Health Care

            pharmaceuticals, electronic medical records, and basic research. "We can't just wait for decentralized approaches to come and save us," Huckman says. "At some point we need to go to the large medical centers, group practices, and View Details
            Keywords: by Carmen Nobel; Health
            • 22 Jan 2014
            • Working Paper Summaries

            Separating Homophily and Peer Influence with Latent Space

            Keywords: by Joseph P. Davin, Sunil Gupta & Mikołaj Jan Piskorski
            • 13 Jul 2023
            • News

            The Network Effect

            between the two companies. In March 2021, Model was a part of the Agios team that finalized the sale of the biotech’s oncology portfolio to international pharmaceutical company Servier. For Agios, the sale was part of a pivot from cancer... View Details
            • 01 Aug 2023
            • Cold Call Podcast

            Can Business Transform Primary Health Care Across Africa?

            Keywords: Re: Regina E. Herzlinger; Pharmaceutical; Pharmaceutical